Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2026 Earnings Call Transcript April 29, 2026
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $0.53, expectations were $0.5.
Operator: Hello, and welcome to the Teva Pharmaceutical Industries Limited Q1 2026 Earnings Conference Call. My name is Alex. and I’ll be coordinating today’s call. [Operator Instructions]. I’ll now hand it over to Chris Stevo, SVP, Investor Relations. Please go ahead.
Christopher...
